Random Transgenic

CETP ApoB100 Random Transgenic Mouse Model
This model is impacted by a newly discovered spontaneous mutation in the Thyroglobulin (Tg) gene. It will be removed over time through selective breeding. See the Fact Sheet for more information.

  • Model #
  • Genotype
  • Nomenclature
  • 3716-F
    B6.SJL-Tg(APOA-CETP)1Dsg Tg(APOB)1102Sgy N10
  • 3716-M
    B6.SJL-Tg(APOA-CETP)1Dsg Tg(APOB)1102Sgy N10
  • This double microinjected model carries both human cholesteryl ester transfer protein and human apolipoprotein B100 transgenes
  • Exhibits human-like serum HDL/LDL distribution
  • When fed a high fat, high cholesterol diet these mice develop foam cell accumulation underlying the endothelium and within the media, and have significantly more complex atherosclerotic lesions than control animals
  • Useful for evaluating compounds to treat hypercholesterolemia or HDL/LDL cholesterol imbalance to reduce the risk of developing atherosclerosis
  • Differs from model 1007 in that the CETP line used to generate this model has been backcrossed for an additional 6 generations to C57BL/6, thereby reducing genes from the SJL strain
Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation.

Genetic Background:

B6.SJL Background


The CETP-ApoB100 microinjected model was developed in the laboratory of David Grass at Xenogen Biosciences, now Taconic, by crossing the ApoB100 microinjected model with the CETP microinjected model. At Taconic, the CETP-ApoB100 model is produced by mating the hemizygous ApoB100 transgenic model (1004) with the homozygous CETP transgenic model (3715).


Wild type for Nnt mutation





Initial Publication:

Grass DS, Saini U, Felkner RH, Wallace RE, Lago WJP, Young SG, Swanson ME. (1995) Transgenic Mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans. J Lipid Res, 36(5): 1082-1090.

Conditions of Use for Taconic Transgenic Models™
Taconic Transgenic Models™ (Models) are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic sells the Models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased Model in consideration of purchasers' acknowledgement of and agreement to the Terms and Conditions for Taconic Models, Products and Services and the following terms of use:
  • Title to these Models and biological materials derived from them remains with Taconic.
  • The Models will be used for research purposes only.
  • The Models will not be bred or cross-bred except to obtain embryos or fetuses required for research purposes unless additional rights have been granted in writing by Taconic.
  • The Models and biological materials derived from them will not be distributed to third parties or used for commercial purposes.
  • Non-profit purchasers may not use this Model and/or biological materials derived from it in sponsored research or contract research studies unless it is purchased at the for-profit price.

Welcome! Tell us a little about yourself